Literature DB >> 3351730

The role of coagulase-negative Staphylococcus in neonatal necrotizing enterocolitis.

D L Mollitt1, J J Tepas, J L Talbert.   

Abstract

Coagulase-negative Staphylococcus has emerged as a prominent pathogen in the neonatal intensive care unit and a recent report has implicated this organism in necrotizing enterocolitis (NEC). This same study suggests that Staphylococcus epidermidis is most commonly associated with a "mild form of enterocolitis." This prompted a review of the role of coagulase-negative Staphylococcus in the surgical complications of NEC. Between 1982 and 1986, 86 newborns underwent operation for perforation or intestinal necrosis secondary to NEC. Blood cultures, obtained within 72 hours of surgery, were positive in nine of 71 infants (13%). One third of these grew coagulase-negative Staphylococcus. Peritoneal cultures obtained at the time of operation were positive in 71 neonates. The incidence of Staphylococcus epidermidis was 30%. In a third of these cases, coagulase-negative Staphylococcus was the only organism covered. Overall mortality within the group was 33%. Coagulase-negative Staphylococcus was the single most frequent organism recovered from those infants who expired (35%). This data clearly indicates that Staphylococcus epidermidis must be considered as a significant pathogen in NEC. It is associated with both morbidity and mortality and, therefore, warrants appropriate aggressive therapy when recovered from the neonate with enterocolitis.

Entities:  

Mesh:

Year:  1988        PMID: 3351730     DOI: 10.1016/s0022-3468(88)80542-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  12 in total

1.  A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units.

Authors:  D Isaacs
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

2.  Low mortality in necrotizing enterocolitis associated with coagulase-negative Staphylococcus infection.

Authors:  Miguel Sáenz de Pipaón Marcos; Juan Rodríguez Delgado; Miriam Martínez Biarge; Jesús Pérez Rodríguez; Grevelyn Sosa Rotundo; Juan A Tovar Larrucea; José Quero Jiménez
Journal:  Pediatr Surg Int       Date:  2008-05-06       Impact factor: 1.827

3.  Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants.

Authors:  Y K Siu; P C Ng; S C Fung; C H Lee; M Y Wong; T F Fok; K W So; K L Cheung; W Wong; A F Cheng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

4.  Role of neutrophil receptors in opsonophagocytosis of coagulase-negative staphylococci.

Authors:  G E Schutze; M A Hall; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

5.  An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization.

Authors:  C Mehlin; C M Headley; S J Klebanoff
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

6.  Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis.

Authors:  Roberto Murgas Torrazza; Maria Ukhanova; Xiaoyu Wang; Renu Sharma; Mark Lawrence Hudak; Josef Neu; Volker Mai
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

Review 7.  Infectious causes of necrotizing enterocolitis.

Authors:  Sarah A Coggins; James L Wynn; Jörn-Hendrik Weitkamp
Journal:  Clin Perinatol       Date:  2014-11-27       Impact factor: 3.430

Review 8.  Neonatal sepsis due to coagulase-negative staphylococci.

Authors:  Elizabeth A Marchant; Guilaine K Boyce; Manish Sadarangani; Pascal M Lavoie
Journal:  Clin Dev Immunol       Date:  2013-05-22

Review 9.  Staphylococcal enterocolitis: forgotten but not gone?

Authors:  Zheng Lin; Donald P Kotler; Patrick M Schlievert; Emilia Mia Sordillo
Journal:  Dig Dis Sci       Date:  2009-07-16       Impact factor: 3.487

Review 10.  Epidemiology of necrotizing enterocolitis.

Authors:  B J Stoll
Journal:  Clin Perinatol       Date:  1994-06       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.